BioStem Technologies, Inc. (OTCMKTS:BSEM) Short Interest Update

BioStem Technologies, Inc. (OTCMKTS:BSEM) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 191,200 shares, an increase of 38.8% from the December 15th total of 137,800 shares. Based on an average daily trading volume, of 98,300 shares, the short-interest ratio is presently 1.9 days.

BioStem Technologies Stock Up 0.8 %

Shares of OTCMKTS BSEM traded up $0.12 during midday trading on Thursday, hitting $15.72. 21,158 shares of the company’s stock were exchanged, compared to its average volume of 51,516. The company’s 50 day moving average price is $15.38 and its 200 day moving average price is $12.63. The firm has a market capitalization of $261.74 million, a PE ratio of 23.12 and a beta of -0.53. BioStem Technologies has a 12 month low of $4.41 and a 12 month high of $28.26.

BioStem Technologies (OTCMKTS:BSEM) last announced its earnings results on Tuesday, November 12th. The company reported $0.32 EPS for the quarter, beating the consensus estimate of $0.31 by $0.01. The business had revenue of $82.56 million for the quarter, compared to the consensus estimate of $78.22 million. On average, equities research analysts anticipate that BioStem Technologies will post 1.41 EPS for the current year.

About BioStem Technologies

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.